Bristol-Myers Squibb Company (NYSE:BMY) under comprehensive financial analysis presented as an active mover. Shares moved down -1.78% to trade at $56.29 in recent trading session. The firm has floated short ration of 2.84%, hold to candle to sentiment indicator of Short Ratio, which was 3.72.
Limelight under Ratio Analysis
Bristol-Myers Squibb Company (NYSE:BMY) has noticeable price to earnings growth ratio of 1.46, which find it more attractive on the other stock that has lower PEG and vice versa. The firm price to earnings ratio calculated as 21.19. The co stands at price to sale ratio of 4.85 that signifies the value placed on each dollar of a firm’s sales or incomes; it is most relevant ratio to compare companies in similar sector. It has price to book ratio of 5.83, which gauges the market price of a share over its book value.
Finally to see some strong financial remarks by WSJ over BMY performance. Out of the pool of analysts 10 gave their BUY ratings on the stock in previous month as 11 analysts having BUY in current month. The stock was ranked as Underweight by 1 analyst while 1 analyst gave SELL rank. Majority ranked Overweight from the pool of analysts.
The next year first quarter EPS estimates trend for current period shows $0.73 while one month ago this estimate trend was for $0.73. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $3.09 and for the one month was for $3.09 as compared to three months ago was for $3.35. BMY received highest price target of 68 and low target of 42. The stock price target chart showed average price target of 56.40 as compared to current price of 56.29.
Bristol-Myers Squibb Company (NYSE:BMY) need to consider for profitability analysis, the firm has profit margin of positive 22.90% to find consistent trends in a firm’s earnings. Gross profit margin and operating profit margin calculated as 74.60% and 30.80% respectively. BMY has returns on investment of 20.00%. The returns on assets were 13.50% that gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of 29.20%, which is measuring profitability by disclosing how much profit generates by BMY with the shareholders’ money.
The firm attains analyst recommendation of 2.40 on scale of 1-5. The co has price volatility of 1.88% for a week and 1.91% for a month. Narrow down focus to firm performance, its weekly performance was -3.48% and monthly performance was 2.29%. The stock price of BMY is moving down from its 20 days moving average with -0.47% and isolated positively from 50 days moving average with 3.22%.
Bristol-Myers Squibb Company (NYSE:BMY) current ratio calculated as 1.60, this value is acceptable if it lies in 1.3% to 3%. But it varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 1.40, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.41, sometimes it remain same with long term debt to equity ratio.